Cargando…
S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428427/ http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7 |
_version_ | 1785090466612510720 |
---|---|
author | Mateos, Maria-Victoria Morillo, Daniel Gatt, Moshe Sebag, Michael Kim, Kihyun Min, Chang-Ki Oriol, Albert Ocio, Enrique Yoon, Sung-Soo Cohen, Yael Chu, Michael Rodríguez-Otero, Paula Avivi, Irit Guo, Yue Krevvata, Maria Peterson, Michelle Beelen, Melissa Vanak, Jill Banerjee, Arnob Magen, Hila |
author_facet | Mateos, Maria-Victoria Morillo, Daniel Gatt, Moshe Sebag, Michael Kim, Kihyun Min, Chang-Ki Oriol, Albert Ocio, Enrique Yoon, Sung-Soo Cohen, Yael Chu, Michael Rodríguez-Otero, Paula Avivi, Irit Guo, Yue Krevvata, Maria Peterson, Michelle Beelen, Melissa Vanak, Jill Banerjee, Arnob Magen, Hila |
author_sort | Mateos, Maria-Victoria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104284272023-08-17 S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) Mateos, Maria-Victoria Morillo, Daniel Gatt, Moshe Sebag, Michael Kim, Kihyun Min, Chang-Ki Oriol, Albert Ocio, Enrique Yoon, Sung-Soo Cohen, Yael Chu, Michael Rodríguez-Otero, Paula Avivi, Irit Guo, Yue Krevvata, Maria Peterson, Michelle Beelen, Melissa Vanak, Jill Banerjee, Arnob Magen, Hila Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428427/ http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Oral Sessions Mateos, Maria-Victoria Morillo, Daniel Gatt, Moshe Sebag, Michael Kim, Kihyun Min, Chang-Ki Oriol, Albert Ocio, Enrique Yoon, Sung-Soo Cohen, Yael Chu, Michael Rodríguez-Otero, Paula Avivi, Irit Guo, Yue Krevvata, Maria Peterson, Michelle Beelen, Melissa Vanak, Jill Banerjee, Arnob Magen, Hila S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title | S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_full | S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_fullStr | S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_full_unstemmed | S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_short | S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
title_sort | s190: first results from the redirectt-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting bcma and gprc5d in patients (pts) with relapsed/refractory multiple myeloma (rrmm) |
topic | Oral Sessions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428427/ http://dx.doi.org/10.1097/01.HS9.0000967672.15362.d7 |
work_keys_str_mv | AT mateosmariavictoria s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT morillodaniel s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT gattmoshe s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT sebagmichael s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT kimkihyun s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT minchangki s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT oriolalbert s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT ocioenrique s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT yoonsungsoo s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT cohenyael s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT chumichael s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT rodriguezoteropaula s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT aviviirit s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT guoyue s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT krevvatamaria s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT petersonmichelle s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT beelenmelissa s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT vanakjill s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT banerjeearnob s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm AT magenhila s190firstresultsfromtheredirectt1studywithteclistamabtectalquetamabtalsimultaneouslytargetingbcmaandgprc5dinpatientsptswithrelapsedrefractorymultiplemyelomarrmm |